NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
SECURED BY THE SECURITIES.


 


	 	Issuance Date: December 7, 2015


 


eWELLNESS HEALTHCARE CORPORATION


Common Stock
Purchase Warrant


 


THIS CERTIFIES
THAT, for value received, FIRSTFIRE GLOBAL OPPORTUNITIES FUND LLC (the “Holder”), is entitled to
subscribe for and purchase, at the Exercise Price (as defined below), from eWELLNESS HEALTHCARE CORPORATION, a Nevada corporation
(the “Company”), shares of the Company’s common stock, par value $0.001 (the “Common Stock”),
at any time prior to the 5:00 p.m., Eastern time, on December 7, 2020 (the “Warrant Exercise Term”).


 


This Warrant is issued
in connection and subject to, the terms and conditions described in the Securities Purchase Agreement, dated December 7, 2015,
between the initial Holder and the Company (the “Agreement”). Capitalized terms used herein and not otherwise
defined shall have the definitions ascribed to such terms in the Agreement. As used herein, the term “Trading Day”
means any day that shares of Common Stock are listed for trading or quotation on the OTCBB (as defined in the Agreement), any tier
of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE MKT (the “Trading Market”).


 


This Warrant is subject
to the following terms and conditions:


 


1. Shares.
The Holder has, subject to the terms set forth herein, the right to purchase up to an aggregate of Two Hundred Fifty Thousand Five
Hundred (250,000) shares (the “Shares”) of Common Stock at a per share exercise price of $0.80 (as subject to
adjustment as provided for herein, the “Exercise Price”).


 


2. Exercise
of Warrant.


 


(a) Exercise.
This Warrant may be exercised by the Holder at any time prior to the expiration of the Warrant Exercise Term, in whole or in part,
by delivering the notice of exercise attached as Exhibit A hereto (the “Notice of Exercise”), duly executed
by the Holder to the Company at its principal office, or at such other office as the Company may designate, accompanied by payment,
in cash by wire transfer of immediately available funds to the order of the Company and to an account designated by the Company,
of the amount obtained by multiplying the number of Shares designated in the Notice of Exercise by the Exercise Price (the “Purchase
Price”). For purposes hereof, “Exercise Date” shall mean the date on which all deliveries required
to be made to the Company upon exercise of this Warrant pursuant to this Section 2(a) shall have been made.


 






    	 	1	 



    	 	 	 



    

 


(b) Issuance
of Shares. Upon receipt by the Company from the Holder of a facsimile transmission or e-mail (or other reasonable means of
communication) of a Notice of Execerice, the Company shall issue and deliver or cause to be issued and delivered to or upon the
order of the Holder certificates for the Shares (or cause the electronic delivery of the Shares as contemplated by Section 2(d)
hereof) within three (3) Trading Days after such receipt (the “Deadline”). If the Company shall fail for any
reason or for no reason to issue to the Holder on or prior to the Deadline a certificate for the number of Shares or to which the
Holder is entitled hereunder and register such Shares on the Company’s share register or to credit the Holder’s balance
account with DTC (as defined below) for such number of Shares to which the Holder is entitled upon the Holder’s exercise
of this Warrant (an “Exercise Failure”), then, in addition to all other remedies available to the Holder, (i)
the Company shall pay in cash to the Holder on each day after the Deadline and during such Exercise Failure an amount equal to
2.0% of the product of (A) the sum of the number of Exercise Shares not issued to the Holder on or prior to the Deadline and to
which the Holder is entitled and (B) the closing sale price of the Common Stock on the Trading Day immediately preceding the last
possible date which the Company could have issued such Shares to the Holder without violating this Section 2(b) and (ii) the Holder,
upon written notice to the Company, may void its Notice of Exercise with respect to, and retain or have returned, as the case may
be, any portion of this Warrant that has not been exercised pursuant to such Notice of Exercise; provided that the voiding of an
Notice of Exercise shall not affect the Company’s obligations to make any payments which have accrued prior to the date of
such notice. In addition to the foregoing, if on or prior to the Deadline the Company shall fail to issue and deliver a certificate
to the Holder and register such Shares on the Company’s share register or credit the Holder’s balance account with
DTC for the number of Shares to which the Holder is entitled upon the Holder’s exercise hereunder or pursuant to the Company’s
obligation pursuant to clause (ii) below, and if on or after such Trading Day the Holder purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon
such exercise that the Holder anticipated receiving from the Company, then the Company shall, within three (3) Trading Days after
the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s
total purchase price (including brokerage commissions and other reasonable and customary out-of-pocket expenses, if any) for the
shares of Common Stock so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver
such certificate (and to issue such Shares) or credit such Holder’s balance account with DTC for such Shares shall terminate,
or (ii) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Shares or credit
such Holder’s balance account with DTC and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In
Price over the product of (A) such number of shares of Common Stock, times (B) the closing sales price of the Common Stock on the
date of exercise. Nothing shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or
in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s
failure to timely deliver certificates representing the Shares (or to electronically deliver such Shares) upon the exercise of
this Warrant as required pursuant to the terms hereof.


 


(c) Obligation of Company
to Deliver Common Stock. Upon receipt by the Company of a Notice of Exercise, the Holder shall be deemed to be the holder
of record of the Shares issuable upon such exercise and all rights with respect to the portion of this Warrant being so exercised
shall forthwith terminate except the right to receive the Common Stock or other securities, cash or other assets, as herein provided,
on such exercise. If the Holder shall have given a Notice of Exercise as provided herein, the Company’s obligation to issue
and deliver the Shares (or cause the electronic delivery of the Shares as contemplated by Section 2(d) hereof) shall be absolute
and unconditional, irrespective of the absence of any action by the Holder to enforce the same, any waiver or consent with respect
to any provision thereof, the recovery of any judgment against any person or any action to enforce the same, any failure or delay
in the enforcement of any other obligation of the Company to the holder of record, or any setoff, counterclaim, recoupment, limitation
or termination, or any breach or alleged breach by the Holder of any obligation to the Company, and irrespective of any other
circumstance which might otherwise limit such obligation of the Company to the Holder in connection with such exercise.


 


(d)
 Delivery of Shares by Electronic Transfer. In lieu of delivering physical certificates representing the Shares
issuable upon exercise hereof, provided the Company is participating in the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer program, upon request of the Holder, the Company shall use its best efforts to cause its transfer
agent to electronically transmit the Share issuable upon exercise hereof to the Holder by crediting the account of Holder’s
Prime Broker with DTC through its Deposit Withdrawal Agent Commission system.


 


(e) Taxes.
The issuance of the Shares upon the exercise of this Warrant, and the delivery of certificates or other instruments representing
such Shares, shall be made without charge to the Holder for any tax or other charge of whatever nature in respect of such issuance
and the Company shall bear any such taxes in respect of such issuance.


 






    	 	2	 



    	 	 	 



    

 


(f) Limitation
on Beneficial Ownership. Notwithstanding anything to the contrary contained herein, that in no event shall the Holder be entitled
to exercise any portion of this Warrant in excess of that portion of this Warrant upon conversion of which the sum of (1) the number
of shares of Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed
beneficially owned through the ownership of the unexercised portion of this Warrant or the unexercised or unconverted portion of
any other security of the Company subject to a limitation on conversion or exercise analogous to the limitations contained herein)
and (2) the number of Shares issuable upon the exercise of the portion of this Warrant with respect to which the determination
of this proviso is being made, would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the
then outstanding shares of Common Stock. The “beneficial ownership” of the Holder shall be determined in accordance
with Section 13(d) of the 1934 Act, and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of above, provided,
however, that the limitations on exercise may be waived by the Holder upon, at the election of the Holder, not less
than 61 days’ prior notice to the Company, and the provisions of the conversion limitation shall continue to apply until
such 61st day (or such later date, as determined by the Holder, as may be specified in such notice of waiver).


 


(g) Cashless
Exercise. Notwithstanding anything contained herein to the contrary, if and only if a registration statement pursuant to the
1933 Act covering the resale of all or any portion of the Warrant Shares is not available for the resale of such Warrant Shares
(such unregistered portion of the Warrant Shares, the “Unavailable Warrant Shares”), the Holder may, in its
sole discretion, exercise this Warrant solely with respect to the Unavailable Warrant Shares and, in lieu of making the cash payment
otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate Exercise Price for such Unavailable
Warrant Shares, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according
to the following formula (a “Cashless Exercise”):


 


	X     =	Y (A - B)	
	 	A	 


 


with:


 


X =  the number
of Warrant Shares to be issued to the Holder


 


Y = the number
of Unavailable Warrant Shares with respect to which the Warrant is being exercised


 


A = the fair value
per share of Common Stock on the date of exercise of this Warrant


 


B = the then-current
Exercise Price of the Warrant


 


Solely for the purposes
of this paragraph, “fair value” per share of Common Stock shall mean (A) the average of the closing sales prices on
the Trading Market for the twenty (20) Trading Days immediately preceding the date on which the Notice of Exercise is deemed to
have been sent to the Company, or (B) if the Common Stock is not publicly traded as set forth above, as reasonably and in good
faith determined by the Board of Directors of the Company as of the date which the Notice of Exercise is deemed to have been sent
to the Company.


 


For purposes of Rule
144 promulgated under the 1933 Act, it is intended, understood and acknowledged that the Warrant Shares issued in a Cashless Exercise
transaction shall be deemed to have been acquired by the Holder, and the holding period for such shares shall be deemed to have
commenced, on the date this Warrant was originally issued.


 






    	 	3	 



    	 	 	 



    

 


3. Adjustment
of Exercise Price and Other Events.


 


(a) Adjustment
for Reclassification, Consolidation or Merger. If while this Warrant, or any portion hereof, remains outstanding and unexpired
there shall be (i) a reorganization or recapitalization (other than a combination, reclassification, exchange or subdivision of
shares otherwise provided for herein), (ii) a merger or consolidation of the Company with or into another corporation or other
entity in which the Company shall not be the surviving entity, or a reverse merger in which the Company shall be the surviving
entity but the shares of the Company’s capital stock outstanding immediately prior to the merger are converted by virtue
of the merger into other property, whether in the form of securities, cash or otherwise, or (iii) a sale or transfer of the Company’s
properties and assets as, or substantially as, an entirety to any other corporation or other entity in one transaction or a series
of related transactions, then, as a part of such reorganization, recapitalization, merger, consolidation, sale or transfer, unless
otherwise directed by the Holder, all necessary or appropriate lawful provisions shall be made so that the Holder shall thereafter
be entitled to receive upon exercise of this Warrant, during the period specified herein and upon payment of the Exercise Price
then in effect, the greatest number of shares of capital stock or other securities or property that a holder of the Shares deliverable
upon exercise of this Warrant would have been entitled to receive in such reorganization, recapitalization, merger, consolidation,
sale or transfer if this Warrant had been exercised immediately prior to such reorganization, recapitalization, merger, consolidation,
sale or transfer, all subject to further adjustment as provided in this Section 3. If the per share consideration payable to the
Holder for Shares in connection with any such transaction is in a form other than cash or marketable securities, then the value
of such consideration shall be determined in good faith by the Company’s Board of Directors. The foregoing provisions of
this paragraph shall similarly apply to successive reorganizations, recapitalizations, mergers, consolidations, sales and transfers
and to the capital stock or securities of any other corporation that are at the time receivable upon the exercise of this Warrant.
In all events, appropriate adjustment shall be made in the application of the provisions of this Warrant with respect to the rights
and interests of the Holder after the transaction, to the end that the provisions of this Warrant shall be applicable after that
event, as near as reasonably may be, in relation to any shares or other property deliverable or issuable after such reorganization,
recapitalization, merger, consolidation, sale or transfer upon exercise of this Warrant.


 


(b) Adjustments
for Split, Subdivision or Combination of Shares. If while this Warrant, or any portion hereof, remains outstanding and unexpired
the Company shall subdivide (by any stock split, stock dividend, recapitalization, reorganization, reclassification or otherwise)
the shares of Common Stock subject to acquisition hereunder, then, after the date of record for effecting such subdivision, the
Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of shares of Common
Stock subject to acquisition upon exercise of the Warrant will be proportionately increased. If the Company at any time combines
(by reverse stock split, recapitalization, reorganization, reclassification or otherwise) the shares of Common Stock subject to
acquisition hereunder, then, after the record date for effecting such combination, the Exercise Price in effect immediately prior
to such combination will be proportionately increased and the number of shares of Common Stock subject to acquisition upon exercise
of the Warrant will be proportionately decreased.


 


(c) Adjustments
for Dividends in Stock or Other Securities or Property. If while this Warrant, or any portion hereof, remains outstanding and
unexpired, the holders of any class of securities as to which purchase rights under this Warrant exist at the time shall have received
or, on or after the record date fixed for the determination of eligible stockholders, shall have become entitled to receive, without
payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of dividend,
then and in each case, this Warrant shall represent the right to acquire, in addition to the number of shares of such class of
security receivable upon exercise of this Warrant, and without payment of any additional consideration therefor, the amount of
such other or additional stock or other securities or property (other than cash) of the Company that such holder would hold on
the date of such exercise had it been the holder of record of the class of security receivable upon exercise of this Warrant on
the date hereof and had thereafter, during the period from the date hereof to and including the date of such exercise, retained
such shares and/or all other additional stock available to it as aforesaid during said period, giving effect to all adjustments
called for during such period by the provisions of this Section 3.


 


(d) Adjustments for
Dilutive Issuances . If, at any time while this Warrant is outstanding, the Company sells or grants any option to purchase
or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase
or other disposition), any Common Stock or other securities entitling any person to acquire shares of Common Stock at an effective
price per share that is lower than the then Exercise Price (such lower price, the “Base Exercise Price” and such issuances,
collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or other securities so issued shall at any
time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or
otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive
shares of Common Stock at an effective price per share that is lower than the Exercise Price, such issuance shall be deemed to
have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced
to equal the Base Exercise Price. Such adjustment shall be made whenever such Common Stock or other securities are issued. Notwithstanding
the foregoing, no adjustment will be made under this Section 3(d) in respect of an Exempt Issuance. In the event of an issuance
of securities involving multiple tranches or closings, any adjustment pursuant to this Section 3(d) shall be calculated as if all
such securities were issued at the initial closing.


 






    	 	4	 



    	 	 	 



    

 


An “Exempt Issuance”
shall mean the issuance of (i) shares of Common Stock or other securities to employees, officers or directors of the Company pursuant
to any stock or option or similar equity incentive plan duly adopted for such purpose, by a majority of the non-employee members
of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose in
a manner which is consistent with the Company’s prior business practices; (ii) securities issued pursuant to a merger, consolidation,
acquisition or similar business combination approved by a majority of the disinterested directors of the Company, provided that
any such issuance shall only be to a person (or to the equityholders of a person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the
Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities;
or (iii) securities issued pursuant to any equipment loan or leasing arrangement, real property leasing arrangement or debt financing
from a bank or similar financial institution approved by a majority of the disinterested directors of the Company.


 


(e) Fundamental Transactions.
The Company shall not enter into or be party to a Fundamental Transaction unless the entity succeeding to the Company (the “Successor
Entity”) assumes in writing all of the obligations of the Company under this Warrant and the Agreement pursuant to written
agreements in form and substance reasonably satisfactory to the Holder. Upon occurrence or consummation of the Fundamental Transaction,
and it shall be a required condition to the occurrence or consummation of such Fundamental Transaction that, the Company and the
Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise of this Warrant at any time
after the occurrence or consummation of the Fundamental Transaction, as elected by the Holder solely at its option, shares of Common
Stock, shares of capital stock of the Successor Entity (“Successor Capital Stock”) or, in lieu of the shares
of Common Stock or Successor Capital Stock (or other securities, cash, assets or other property purchasable upon the exercise of
this Warrant prior to such Fundamental Transaction), such shares of stock, securities, cash, assets or any other property whatsoever
(including warrants or other purchase or subscription rights), which for purposes of clarification may continue to be shares of
Common Stock, if any, that the Holder would have been entitled to receive upon the happening of such Fundamental Transaction or
the record, eligibility or other determination date for the event resulting in such Fundamental Transaction, had this Warrant been
exercised immediately prior to such Fundamental Transaction or the record, eligibility or other determination date for the event
resulting in such Fundamental Transaction, as adjusted in accordance with the provisions of this Warrant. In addition to and not
in substitution for any other rights hereunder, prior to the occurrence or consummation of any Fundamental Transaction pursuant
to which holders of shares of Common Stock are entitled to receive securities, cash, assets or other property with respect to or
in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to
insure that, and any applicable Successor Entity shall ensure that, and it shall be a required condition to the occurrence or consummation
of such Corporate Event that, the Holder will thereafter have the right to receive upon exercise of this Warrant at any time after
the occurrence or consummation of the Corporate Event, shares of Common Stock or Successor Capital Stock or, if so elected by the
Holder, in lieu of the shares of Common Stock (or other securities, cash, assets or other property) purchasable upon the exercise
of this Warrant prior to such Corporate Event. The provisions of this Section 2(e) shall apply similarly and equally to successive
Fundamental Transactions and Corporate Events.


 


(f) Black Scholes Purchase.
Notwithstanding the foregoing, in the event of a Fundamental Transaction, at the written request of the Holder delivered before
the thirtieth (30th) day after the consummation of such Fundamental Transaction, the Company (or the Successor Entity) shall purchase
this Warrant from the Holder by paying to the Holder, within ten (10) Business Days after such request (or, if later, on the effective
date of the Fundamental Transaction), cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of
this Warrant on the date of such Fundamental Transaction.


 






    	 	5	 



    	 	 	 



    

 


(g) As used herein, the
term “Fundamental Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company
is the surviving corporation) another entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties or assets of the Company to one or more entities, or (iii) make, or allow one or more entities to make, or
allow the Company to be subject to or have its Common Stock be subject to or party to one or more entities making, a purchase,
tender or exchange offer that is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock,
(y) 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all entities making or party
to, or affiliated with any entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such
number of shares of Common Stock such that all entities making or party to, or Affiliated with any entity making or party to, such
purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of
at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more entities
whereby all such entities, individually or in the aggregate, acquire, either (x) at least 50% of the outstanding shares of Common
Stock, (y) at least 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all the entities
making or party to, or affiliated with any entity making or party to, such stock purchase agreement or other business combination
were not outstanding; or (z) such number of shares of Common Stock such that the entities become collectively the beneficial owners
(as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize
or reclassify its Common Stock such that such modified Common Stock no longer has the residual right to dividends or distributions
form the Company or the residual right to vote on matters given to the common stock holders under Nevada law, (B) that the Company
shall, directly or indirectly, including through subsidiaries, affiliates or otherwise, in one or more related transactions, allow
any entity individually or entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3
under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer,
exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization, recapitalization,
spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of
either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least
50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such entities as
of the date of this Warrant calculated as if any shares of Common Stock held by all such entities were not outstanding, or (z)
a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity
securities of the Company sufficient to allow such entities to effect a statutory short form merger or other transaction requiring
other stockholders of the Company to surrender their shares of Common Stock without approval of the stockholders of the Company
or (C) directly or indirectly, including through subsidiaries, affiliates or otherwise, in one or more related transactions, the
issuance of or the entering into any other instrument or transaction structured in a manner to circumvent, or that circumvents,
the intent of this definition in which case this definition shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this definition to the extent necessary to correct this definition or any portion of this definition
which may be defective or inconsistent with the intended treatment of such instrument or transaction.


 


(h) As used herein, the
term “Black Scholes Value” means the value of this Warrant based on the Black and Scholes Option Pricing Model
obtained from the “OV” function on Bloomberg determined as of the day immediately following the public announcement
of the applicable Fundamental Transaction, or, if the Fundamental Transaction is not publicly announced, the date the Fundamental
Transaction is consummated, for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury
rate for a period equal to the remaining term of this Warrant as of such date of request, (ii) an expected volatility equal to
the greater of 100% and the 30 day volatility obtained from the HVT function on Bloomberg as of the day immediately following the
public announcement of the applicable Fundamental Transaction, or, if the Fundamental Transaction is not publicly announced, the
date the Fundamental Transaction is consummated, (iii) the underlying price per share used in such calculation shall be the sum
of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in the
Fundamental Transaction, (iv) a zero cost of borrow and (v) a 360 day annualization factor.


 


(i) Notice of Fundamental
Transactions and Adjustments. The Company shall provide the Holder with no less than five (5) business days written notice
of the public announcement of any Fundamental Transaction. In addition, upon any adjustment of the Exercise Price and any increase
or decrease in the number of Shares purchasable upon the exercise of this Warrant, then, and in each such case, the Company, within
30 days thereafter, shall give written notice thereof to the Holder at the address of such Holder as shown on the books of the
Company, which notice shall state the Exercise Price as adjusted and, if applicable, the increased or decreased number of Shares
purchasable upon the exercise of this Warrant, setting forth in reasonable detail the method of calculation of each.


 






    	 	6	 



    	 	 	 



    

 


4. Notices.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be undertaken in accordance
with the provisions of Section 8(f) of the Agreement.


 


5. Removal
of Legend. The Holder shall have the right to cause restrictive legends removed from the Shares as provided for in the Agreement.


 


6. Fractional
Shares. No fractional Shares will be issued in connection with any exercise hereunder. Instead, the Company shall round up,
as nearly as practicable to the nearest whole Share, the number of Shares to be issued.


 


7. Rights
of Stockholder. Except as expressly provided in Section 3 hereof, the Holder, as such, shall not be entitled to vote or receive
dividends or be deemed the holder of the Shares or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the
rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders
at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of
stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of
meetings, or otherwise until this Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have
been issued, as provided herein.


 


8. Transfer;
Multiple Warrants; Lost Warrant; New Warrants. This Warrant and the Shares may be offered for sale, sold, transferred, pledged
or assigned without the consent of the Company, provided that any such offer, sale, transfer, pledge or assignment must be undertaken
in accordance with applicable law, rule and regulation (including the 1933 Act). This Warrant is exchangeable, upon the surrender
hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants representing in the aggregate the right
to purchase the number of Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such
portion of such Shares as is designated by the Holder at the time of such surrender. Upon receipt by the Company of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction,
of any indemnification undertaking by the Holder to the Company in customary form and, in the case of mutilation, upon surrender
and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant representing the right to purchase
the Warrant Shares then underlying this Warrant. Whenever the Company is required to issue a new Warrant pursuant to the terms
of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face
of such new Warrant, the right to purchase the Shares then underlying this Warrant (or in the case of a new Warrant being issued
pursuant to this Section 8, the Shares designated by the Holder which, when added to the number of shares of Common Stock underlying
the other new Warrants issued in connection with such issuance, does not exceed the number of Shares then underlying this Warrant),
(iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv)
shall have the same rights and conditions as this Warrant.


 


9. Miscellaneous.


 


(a) This Warrant
and disputes arising hereunder shall be governed by and construed and enforced in accordance with the laws of the State of Nevada
applicable to agreements made and to be performed wholly within such State, without regard to its conflict of law rules. Venue
for resolution of disputes shall be as provided for in the Agreement.


 


(b) The headings
in this Warrant are for purposes of reference only, and shall not limit or otherwise affect any of the terms hereof.


 


(c) The covenants
of the respective parties contained herein shall survive the execution and delivery of this Warrant.


 






    	 	7	 



    	 	 	 



    

 


(d) The terms
of this Warrant shall be binding upon and shall inure to the benefit of any successors or permitted assigns of the Company and
of the Holder and of the Shares issued or issuable upon the exercise hereof.


 


(e) This Warrant
and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties
with regard to the subject hereof.


 


(f) The Company
shall not, by amendment of its Certificate or Articles of Incorporation or Bylaws, or through any other means, directly or indirectly,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant and shall at all times in good faith assist
in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect
the rights of the Holder contained herein against impairment.


 


(g) Upon receipt
of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case
of any such loss, theft or destruction, upon delivery of an indemnity agreement reasonably satisfactory in form and amount to the
Company, or, in the case of any such mutilation, upon surrender and cancellation of such Warrant, the Company, at its expense,
will execute and deliver to the Holder, in lieu thereof, a new Warrant of like date and tenor.


 


(h) This Warrant
and any provision hereof may be amended, waived or terminated only by an instrument in writing signed by the Company and the Holder.


 


IN WITNESS WHEREOF,
the Company has caused this Warrant to be signed by its duly authorized officer.


 


	 	eWELLNESS HEALTHCARE CORPORATION
	 	 
	 	By: 	 
	 	Name:	Darwin Fogt 
	 	Title:	Chief Executive Officer


 




    	 	8	 



    	 	 	 



    


 


Exhibit A


 


EXERCISE NOTICE


TO BE EXECUTED BY THE REGISTERED HOLDER TO
EXERCISE THIS


WARRANT TO PURCHASE COMMON STOCK


 


eWELLNESS HEALTHCARE CORPORATION 


 


The undersigned holder
hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”) of
eWELLNESS HEALTHCARE CORPORATION, a Nevada corporation (the “Company”), evidenced by the attached Common
Stock Purchase Warrant (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the
respective meanings set forth in the Warrant.


 


The holder shall tender
payment for such shares of Common Stock (i) in the sum of $___________________ to the Company in accordance with the terms of the
Warrant or (ii) via cashless exercise, in each case in accordance with the terms hereof.


 


The Company shall deliver
to the holder __________ Warrant Shares:


 


 ______ in certificated form


 


 _____ through the facilities of the
DTC via the following instructions:


 


________________________________


________________________________


________________________________


 


Date: _______________ __, ______


 


	 	 	 
	Name of Registered Holder	 
	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 


 




    	 	9	 



    	 	 	 



    


 


Exhibit B


 


FORM OF ASSIGNMENT


 


FOR VALUE RECEIVED, ___________________________________
hereby sells, assigns and transfers to each assignee set forth below all of the rights of the undersigned under the Warrant (as
defined in and evidenced by the attached Warrant) to acquire the number of Shares set opposite the name of such assignee below
and in and to the foregoing Warrant with respect to said acquisition rights and the shares issuable upon exercise of the Warrant:


 


	Name of Assignee	 	Address	 	Number of Shares
	
         
				
	
         
	 	 	 	 
	
         
	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 


 


If the total of the Shares
are not all of the Shares evidenced by the foregoing Warrant, the undersigned requests that a new Warrant evidencing the right
to acquire the Shares not so assigned be issued in the name of and delivered to the undersigned.


  





	 	Name of Holder (print):	 





	 	(Signature): 	 
	 	(By:) 	 
	 	(Title:) 	 
	 	Dated:  	 


 






    	 	10